智通财经APP获悉，诺和诺德公司（Novo Nordisk） ...

智通财经获悉，美国食品和药物管理局(FDA)周一批准了Hikma仿制诺和诺德(NVO.US)糖尿病药物Victoza，为该药物的另一种仿制药在美国上市扫清了道路。Hikma的品牌仿制药将与Teva制药公司竞争，Teva制药公司今年早些时候在美国推出了 ...

智通财经APP获悉，诺和诺德 (NVO.US)周五表示，新一代实验性减肥药CagriSema在一项后期试验中帮助超重患者减轻了22.7%的体重，低于预期的25%。受该消息影响，诺和诺德股价盘前大跌23%，而其对手礼来 (LLY.US)涨近10%。

Investors in Novo-Nordisk AS (Symbol: NVO) saw new options begin trading today, for the February 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NVO ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet year ...

诺和诺德(NVO.US)将投资85亿丹麦克朗(约合12亿美元)在丹麦新建一家大型工厂，以满足市场对其重磅药品日益增长的需求。

12月20日， 诺和诺德 ...

(Photo by Mads Claus Rasmussen / Ritzau Scanpix / AFP) / Denmark OUT (Photo by MADS CLAUS RASMUSSEN/Ritzau Scanpix/AFP via Getty Images) Novo Nordisk ADR (NYSE: NVO) currently trades at $89 per ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

12/16，诺和诺德（Novo Nordisk） $诺和诺德 (NVO)$ 近期迎来一系列积极发展，其主要股东诺和控股（Novo Holdings）即将完成对合同开发与生产机构Catalent的收购，同时诺和诺德也于周一宣布将在丹麦新建一处生产设施。

Novo Nordisk (NVO) closed at $85.73 in the latest trading session, marking a -1.88% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 1.07% for the day.